Ranexa 500 mg
As listed in the register: Ranexa 500 mg, tablet met verlengde afgifte
500 mg · tablet met verlengde afgifte
- Prescription only
- Heart, blood pressure and circulation
- Active substance
- Ranolazine
- Made by
- Menarini International Operations Luxembourg S.A.
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United States29 matching products
European UnionNo exact match for this strength and form
Spain18 matching products
- RANEXA 500 mg · comprimido de liberación prolongada6 makers
- LABIGAT 500 mg · comprimido de liberación prolongada
- RANOLAZINA ALTER 500 MG · comprimido de liberación prolongada
- RANOLAZINA AUROVITAS 500 mg · comprimido de liberación prolongada
- RANOLAZINA CINFA 500 mg · comprimido de liberación prolongada
- RANOLAZINA INTAS 500 MG · comprimido de liberación prolongada
- RANOLAZINA KRKA 500 mg · comprimido de liberación prolongada
- RANOLAZINA NORMON 500 mg · comprimido de liberación prolongada
Canada2 matching products
SwitzerlandNo exact match for this strength and form
Details
| Made by | Menarini International Operations Luxembourg S.A. |
|---|---|
| Active substance | Ranolazine |
| Used in | Heart, blood pressure and circulation |
| Strength | 500 mg |
| Form | tablet met verlengde afgifte |
| Classification | C01EB18 · Heart, blood pressure and circulation |
| Route | oraal gebruik |
| Dispensing (as stated by the register) | Uitsluitend recept |
| Name in the register | Ranexa 500 mg, tablet met verlengde afgifte |
| RVG | EU/1/08/462 |
Source: Geneesmiddeleninformatiebank · 2026-09-30 · not reviewed by a clinician
Bron: College ter Beoordeling van Geneesmiddelen (CBG). De Rijksoverheid is het niet automatisch eens met de inhoud van deze site. Reuse terms: CC0 1.0 (CBG website).
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.